42125-46-2

Basic information

• Product Name: 4-tert-Butylcyclohexyl chloroformate
• Synonyms: 4-T-BUTYLCYCLOHEXYL CHLOROFORMATE;4-butylcyclohexylchloroformate;4-tert-Butylcyclohexylchloroformate;Carbonochloridicacid,4-(1,1-dimethylethyl)cyclohexylester;Chloridocarbonic acid 4-(1,1-dimethylethyl)cyclohexyl ester;t-butyl cyclohexyl chloroforMate;4-(tert-Butyl)cyclohexyl carbonochloridate
• CAS NO: 42125-46-2
• Molecular Formula: C₁₁H₁₉ClO₂
• Molecular Weight: 218.72
• EINECS: 255-670-9
• Product Categories: CHLOROFORMATES;API intermediates
• Mol File: 42125-46-2.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 254.9 °C at 760 mmHg
• Flash Point: 84.2 °C
• Appearance: /
• Density: 1.05 g/cm³
• Vapor Pressure: 0.0168mmHg at 25°C
• Refractive Index: 1.465
• CAS DataBase Reference: 4-tert-Butylcyclohexyl chloroformate(CAS DataBase Reference)
• NIST Chemistry Reference: 4-tert-Butylcyclohexyl chloroformate(42125-46-2)
• EPA Substance Registry System: 4-tert-Butylcyclohexyl chloroformate(42125-46-2)

Safety Data

• Hazardous Substances Data: 42125-46-2(Hazardous Substances Data)

Usage

Uses

4-tert-Butylcyclohexyl Chloroformate is an intermediate in the synthesis of Bis(4-(tert-butyl)cyclohexyl) Peroxydicarbonate (B592234) which is a useful raw material used in the preparation of polymerizable yellow azo dyes applied in artificial intraocular lens. A catalyst.

InChI:InChI=1/C11H19ClO2/c1-11(2,3)8-4-6-9(7-5-8)14-10(12)13/h8-9H,4-7H2,1-3H3

Upstream product

• 32315-10-9 bis(trichloromethyl) carbonate 
• 98-52-2 4-(1,1-dimethylethyl)-cyclohexanol 
• 75-44-5 phosgene 

Downstream Products

• 15520-11-3  
• 37653-73-9 (4-Chlorocarbonyl-phenyl)-carbamic acid 4-tert-butyl-cyclohexyl ester 
• 89546-66-7 cis-4-t-butylcyclohex-2-enyl chloride 
• 31824-02-9 cis-5-t-butylcyclohex-2-enyl chloride 
• 31824-02-9 trans-5-t-butylcyclohex-2-enyl chloride 
• 17502-34-0 cis-5-tert-butylcyclohex-2-en-1-ol 
• 17502-34-0 trans-5-tert-butyl-2-cyclohexenol 
• 125076-75-7 C₁₄H₂₄O₃S₂ 
• 13145-48-7 trans-4-tert-butyl-1-chlorocyclohexane 
• 13131-74-3 cis-4-tert-butylcyclohexyl chloride 
• 2228-98-0 4-tert-butylcylohexene 
• 37653-98-8 4-(4-tert-Butyl-cyclohexyloxycarbonylamino)-benzoic acid 

Relevant articles and documents

Discovery of (3-Benzyl-5-hydroxyphenyl)carbamates as new antitubercular agents with potent in vitro and in vivo efficacy

A series of 3-amino-5-benzylphenol derivatives were designed and synthesized. Among them, (3-benzyl-5-hydroxyphenyl)carbamates were found to exert good inhibitory activity against M. tuberculosis H37Ra, H37Rv and clinically isolated multidrug-resistant M. tuberculosis strains (MIC = 0.625-6.25 μg/mL). The privileged compounds 3i and 3l showed moderate cytotoxicity against cell line A549. Compound 3l also exhibited potent in vivo inhibitory activity on a mouse infection model via the oral administration. The results demonstrated 3-hydroxyphenylcarbamates as a class of new antitubercular agents with good potential.

Second generation fluorous DEAD reagents have expanded scope in the Mitsunobu reaction and retain convenient separation features

First generation fluorous DEAD reagent bis(perfluorohexylethyl)azo dicarboxylate (C6F13(CH2)2O 2-CN=NCO2(CH2)2C6F13, F-DEAD-1) has been shown to underperform relative to diisopropylazodicarboxylate in difficult Mitsunobu reactions involving hindered alcohols or less acidic pronucleophiles (phenols). Two new second generation fluorous reagents bearing propylene spacers instead of the ethylene spacers show expanded reaction scope while retaining the easy fluorous separation features. Byproducts from "half fluorous" reagent perfluorooctylpropyl tert-butyl azo dicarboxylate (C8F17(CH2)3O 2CN=NCO2tBu, F-DEAD-2) can be removed by fluorous flash chromatography, and byproducts from bis(perfluorohexylpropyl)azo dicarboxylate (C6F13(CH2)3O 2CN=NCO2(CH2)3C6F 13, F-DEAD-3) can be removed by fluorous solid-phase extraction. The new reagents promise to provide general and complementary solutions for separation problems in Mitsunobu reactions without restricting reaction scope.